Hao Bao - Publications

Enoxolone Alleviates Renal Fibrosis in Diabetic Kidney Disease by Inhibiting the Smad3-Smad4 Complex.

Journal: Kidney diseases (Basel, Switzerland)

Published: April 11, 2026

Efficacy and safety of finerenone in non-diabetic patients with IgA nephropathy.

Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association

Published: September 15, 2025

Association between Anti-Nephrin Antibodies and Podocytopathies: A Systematic Review and Meta-Analysis.

Journal: Nephron

Published: July 23, 2025

Nuclear Factor Erythroid 2-Related Factor 2 Activator DDO-1039 Ameliorates Podocyte Injury in Diabetic Kidney Disease via Suppressing Oxidative Stress, Inflammation, and Ferroptosis.

Journal: Antioxidants & redox signaling

Published: December 26, 2024

RGD-HSA-TAC nanoparticles targeted delivery of tacrolimus and attenuation of podocyte injury in diabetic kidney disease.

Journal: Journal of nanobiotechnology

Published: October 23, 2024

Engineered RGD-Treg-Exos Targeted Delivery of miR-218-5p to Activate Mitophagy and Attenuate Podocyte Injury in Diabetic Kidney Disease.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: September 28, 2024

Screening of potential drugs for the treatment of diabetic kidney disease using single-cell transcriptome sequencing and connectivity map data.

Journal: Biochemical and biophysical research communications

Published: April 18, 2024

Role of TSP-1 and its receptor ITGB3 in the renal tubulointerstitial injury of focal segmental glomerulosclerosis.

Journal: The Journal of biological chemistry

Published: February 20, 2024

CD8 T Cell-Derived Exosomal miR-186-5p Elicits Renal Inflammation via Activating Tubular TLR7/8 Signal Axis.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: March 07, 2023

Upregulated LRRC55 promotes BK channel activation and aggravates cell injury in podocytes.

Journal: The Journal of experimental medicine

Published: December 19, 2019

C3a and suPAR drive versican V1 expression in tubular cells of focal segmental glomerulosclerosis.

Journal: JCI insight

Published: July 12, 2019

The long noncoding RNA LOC105374325 causes podocyte injury in individuals with focal segmental glomerulosclerosis.

Journal: The Journal of biological chemistry

Published: August 29, 2018